Search research articles
Contact Us
Filters
Showing results (91-100 of 123) with videos related to
Page
of 13
Sort By:
Frontiers in Pharmacology
|
January 29, 2019
Y<sub>6</sub>, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
Rui-Qiang Zhao, Yan Wen, Pranav Gupta, et al.
Molecules (Basel, Switzerland)
|
September 21, 2016
Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells
Xiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Cancers
|
February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat Resistance
Rishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Cancer Letters
|
October 14, 2018
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
Ning Ji, Yuqi Yang, Chao-Yun Cai, et al.
Biochemical Pharmacology
|
November 16, 2018
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Ning Ji, Yuqi Yang, Zi-Ning Lei, et al.
Frontiers in Cell and Developmental Biology
|
April 8, 2021
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
Zi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, et al.
Cancers
|
September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
Yunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.
Cancer Letters
|
December 15, 2019
Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia
Pranav Gupta, Guan-Nan Zhang, Anna Maria Barbuti, et al.
Cancers
|
February 27, 2020
Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
Guan-Nan Zhang, Pranav Gupta, Ming Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
February 28, 2018
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells
Pranav Gupta, Yun-Kai Zhang, Xiao-Yu Zhang, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 123) with videos related to
Sort By:
Page
of 13
Frontiers in Pharmacology
|
January 29, 2019
Y<sub>6</sub>, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
Rui-Qiang Zhao, Yan Wen, Pranav Gupta, et al.
Molecules (Basel, Switzerland)
|
September 21, 2016
Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells
Xiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Cancers
|
February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat Resistance
Rishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Cancer Letters
|
October 14, 2018
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
Ning Ji, Yuqi Yang, Chao-Yun Cai, et al.
Biochemical Pharmacology
|
November 16, 2018
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Ning Ji, Yuqi Yang, Zi-Ning Lei, et al.
Frontiers in Cell and Developmental Biology
|
April 8, 2021
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
Zi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, et al.
Cancers
|
September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
Yunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.
Cancer Letters
|
December 15, 2019
Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia
Pranav Gupta, Guan-Nan Zhang, Anna Maria Barbuti, et al.
Cancers
|
February 27, 2020
Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
Guan-Nan Zhang, Pranav Gupta, Ming Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
February 28, 2018
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells
Pranav Gupta, Yun-Kai Zhang, Xiao-Yu Zhang, et al.
Page
of 13